Pharmafile Logo

A New Managing Director Appointed for Lighthouse Medical Communications US

Lucid Group boost their US operations with the appointment of Andy Willmer as Managing Director for Lighthouse Medical Communications

- PMLiVE

Lighthouse Medical Communications US (part of the Lucid Group) is pleased to announce the appointment of Andy Willmer to the position of Managing Director, leading the US operation and championing the growth of the group in the US market. Andy will lead the communications team in the delivery of exceptional medical education and disease understanding programmes, publications and communications planning, peer-to-peer medical communications and medical advocacy development. 

Andy brings an abundance of pharmaceutical, healthcare marketing and brand communications experience, having previously held senior positions within Pharmacia, Biovail and Roche, and most recently on the agency side with Ogilvy CommonHealth in the USA, where he held the position of General Manager, Medical Marketing.  

Lighthouse Medical Communications has experienced rapid growth since it was founded in 2014, predominately capitalising on US domestic business opportunities, with a view to expanding programmes on a global level. Lighthouse already has an impressive client roster and has been busy focusing on the needs of their clients, primarily working in womens’ health and novel biologic immuno-oncologic therapies.  

Dennis O’Brien (Lucid CEO and Co-Founder) commented, “Andy is a great fit with the team – and his history and experience in US and Global Pharma communications, both agency and client side, made him the ideal choice to head the Lighthouse Communications team in the US.  Andy shares our passion to create magical programmes that transform patients’ lives by improving outcomes”

“I’m thrilled to be leading such a smart and dynamic team. The Lighthouse (Lucid) approach of building strategic medical communications which can change lives is rewarding and where I want to be.” commented Andy. 

Andy can be contacted at: E: andy@weareteamlighthouse.com  
T:  +1 646 710 7736   M: +1 908 200 1145

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

A summer meeting full of magical moments

In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...

Sir Henry presents Queen’s Award for Enterprise to Lucid Group

On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...

Lucid Group’s winning formula is recognised at Communiqué 2017

Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

Your career starts here

When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...

Are you suffering from templatitis?

At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...

It’s time to shine for Lucid’s rare disease team

No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.